TY - JOUR T1 - Increasing human papilloma virus (HPV) vaccination uptake in people living with HIV: the need to improve both clinician training and health promotion JF - Sexually Transmitted Infections JO - Sex Transm Infect SP - 536 LP - 536 DO - 10.1136/sextrans-2021-055293 VL - 98 IS - 7 AU - Miriam Ringshall AU - Caroline Cable AU - Colin Fitzpatrick AU - Daniel Richardson Y1 - 2022/11/01 UR - http://sti.bmj.com/content/98/7/536.abstract N2 - Human papilloma virus (HPV) vaccination is recommended for some people living with HIV (PLWHIV) including men who have sex with men (MSM) up to 45 years old.1 HIV clinics are well placed to deliver HPV vaccination due to patients’ regular attendance for routine monitoring and other health interventions. There is little recent evidence on the uptake and barriers to HPV vaccination in PLWHIV.2 A recent meta-analysis suggested that MSM are receptive to HPV vaccination, but vaccine uptake and completion are below prediction, and additional support and resources are needed to provide optimal vaccination rates.3 Uptake of HPV vaccination in MSM is dependent on both patient perceptions of HPV vaccination and clinician beliefs and offer of vaccine to patients.4–8 As part of a service development project, we reviewed the records of MSM under 46 years who attended for HIV care between January 2020 and June 2021. A random selection … ER -